3-124329917-C-T

Variant summary

Our verdict is Benign. The variant received -11 ACMG points: 0P and 11B. BP4BP6BP7BA1

The NM_001388419.1(KALRN):​c.1341C>T​(p.Ser447Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0859 in 1,613,416 control chromosomes in the GnomAD database, including 6,590 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (no stars).

Frequency

Genomes: 𝑓 0.10 ( 908 hom., cov: 31)
Exomes 𝑓: 0.084 ( 5682 hom. )

Consequence

KALRN
NM_001388419.1 synonymous

Scores

2

Clinical Significance

Benign no assertion criteria provided B:1

Conservation

PhyloP100: -5.44
Variant links:
Genes affected
KALRN (HGNC:4814): (kalirin RhoGEF kinase) Huntington's disease (HD), a neurodegenerative disorder characterized by loss of striatal neurons, is caused by an expansion of a polyglutamine tract in the HD protein huntingtin. This gene encodes a protein that interacts with the huntingtin-associated protein 1, which is a huntingtin binding protein that may function in vesicle trafficking. [provided by RefSeq, Apr 2016]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -11 ACMG points.

BP4
Computational evidence support a benign effect (REVEL=0.269).
BP6
Variant 3-124329917-C-T is Benign according to our data. Variant chr3-124329917-C-T is described in ClinVar as [Benign]. Clinvar id is 3057229.Status of the report is no_assertion_criteria_provided, 0 stars.
BP7
Synonymous conserved (PhyloP=-5.44 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.15 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KALRNNM_001388419.1 linkc.1341C>T p.Ser447Ser synonymous_variant Exon 8 of 60 ENST00000682506.1 NP_001375348.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KALRNENST00000682506.1 linkc.1341C>T p.Ser447Ser synonymous_variant Exon 8 of 60 NM_001388419.1 ENSP00000508359.1 A0A804HLI0

Frequencies

GnomAD3 genomes
AF:
0.103
AC:
15576
AN:
151734
Hom.:
908
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.144
Gnomad AMI
AF:
0.133
Gnomad AMR
AF:
0.104
Gnomad ASJ
AF:
0.139
Gnomad EAS
AF:
0.160
Gnomad SAS
AF:
0.0873
Gnomad FIN
AF:
0.0685
Gnomad MID
AF:
0.153
Gnomad NFE
AF:
0.0762
Gnomad OTH
AF:
0.121
GnomAD2 exomes
AF:
0.0961
AC:
24140
AN:
251236
AF XY:
0.0944
show subpopulations
Gnomad AFR exome
AF:
0.147
Gnomad AMR exome
AF:
0.105
Gnomad ASJ exome
AF:
0.145
Gnomad EAS exome
AF:
0.165
Gnomad FIN exome
AF:
0.0705
Gnomad NFE exome
AF:
0.0760
Gnomad OTH exome
AF:
0.104
GnomAD4 exome
AF:
0.0842
AC:
123068
AN:
1461564
Hom.:
5682
Cov.:
31
AF XY:
0.0846
AC XY:
61533
AN XY:
727066
show subpopulations
African (AFR)
AF:
0.141
AC:
4718
AN:
33466
American (AMR)
AF:
0.105
AC:
4704
AN:
44710
Ashkenazi Jewish (ASJ)
AF:
0.147
AC:
3835
AN:
26132
East Asian (EAS)
AF:
0.149
AC:
5894
AN:
39672
South Asian (SAS)
AF:
0.0937
AC:
8077
AN:
86224
European-Finnish (FIN)
AF:
0.0725
AC:
3869
AN:
53400
Middle Eastern (MID)
AF:
0.108
AC:
625
AN:
5768
European-Non Finnish (NFE)
AF:
0.0772
AC:
85786
AN:
1111814
Other (OTH)
AF:
0.0921
AC:
5560
AN:
60378
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.470
Heterozygous variant carriers
0
5413
10827
16240
21654
27067
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
3380
6760
10140
13520
16900
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.103
AC:
15584
AN:
151852
Hom.:
908
Cov.:
31
AF XY:
0.102
AC XY:
7537
AN XY:
74200
show subpopulations
African (AFR)
AF:
0.144
AC:
5956
AN:
41346
American (AMR)
AF:
0.104
AC:
1589
AN:
15254
Ashkenazi Jewish (ASJ)
AF:
0.139
AC:
483
AN:
3466
East Asian (EAS)
AF:
0.159
AC:
817
AN:
5132
South Asian (SAS)
AF:
0.0864
AC:
415
AN:
4806
European-Finnish (FIN)
AF:
0.0685
AC:
724
AN:
10566
Middle Eastern (MID)
AF:
0.161
AC:
47
AN:
292
European-Non Finnish (NFE)
AF:
0.0762
AC:
5179
AN:
67978
Other (OTH)
AF:
0.120
AC:
253
AN:
2100
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.522
Heterozygous variant carriers
0
704
1407
2111
2814
3518
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
174
348
522
696
870
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0900
Hom.:
1070
Bravo
AF:
0.108
Asia WGS
AF:
0.111
AC:
386
AN:
3478
EpiCase
AF:
0.0829
EpiControl
AF:
0.0868

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link

Submissions by phenotype

KALRN-related disorder Benign:1
Nov 25, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.70
CADD
Benign
1.0
DANN
Benign
0.54
PhyloP100
-5.4
Mutation Taster
=84/16
polymorphism (auto)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2276740; hg19: chr3-124048764; COSMIC: COSV53755376; COSMIC: COSV53755376; API